Skip to main content
    V

    Valneva SE ADR (VALN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.62
    -0.03 (-0.53%)

    Market Cap: $538.42M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Valneva SE ADR (VALN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Valneva SE ADR (VALN) has a market cap of $538.42M. Its share count is up 23.25% from a year earlier. It kept -110.21% of revenue as net income over the last 12 months.

    Total Valuation

    Market Cap$538.42M
    Latest price (Nov 17, 2026)$5.62

    Key Dates

    The next earnings report is expected on Nov 24, 2026, covering the quarter ending Sep 30, 2026.

    Next Earnings DateNov 24, 2026 (expected)
    Last Earnings DateAug 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 10.20% in the quarter ended Jun 30, 2026 and grew 20.07% a year over 2 years.

    Shares Outstanding94.82M
    Shares Change (YoY)+23.25%
    Shares Change (QoQ)+10.20%
    Share Count Growth (2Y CAGR)+20.07%

    Valuation Ratios

    Sales and book value multiples are 3.2x and 5.8x. Its year-end P/S ranged from 1.7x to 6.9x from 2021 to 2025.

    P/S Ratio3.2x
    P/B Ratio5.8x
    P/TBV Ratio7.8x

    Valuation history and multiples

    Price Statistics

    The stock is down 37.90% over 52 weeks and trades 5.07% below its 50-day average.

    Beta (1Y)0.52
    52-Week Change-37.90%
    1-Month Change+2.00%
    3-Month Change-17.84%
    6-Month Change-2.43%
    5-Year Change-87.78%
    Total Return (1Y)-37.90%
    Total Return (3Y CAGR)-23.57%
    Total Return (5Y CAGR)-35.20%
    Return vs SPY (1Y)-47.62%
    Max Drawdown (1Y)-60.13%
    Max Drawdown (3Y)-70.97%
    Sharpe Ratio (1Y)-0.63
    Correlation with SPY (1Y)0.10
    50-Day Average$5.92
    200-Day Average$6.58
    52-Week Range$4.75 to $12.18
    RSI (14 Days)47.3
    Average Volume (20 Days)18.44K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.16x current liabilities, and total debt is 2.27x shareholder equity.

    Current Ratio2.16x
    Quick Ratio1.69x
    Debt / Equity2.27x
    Interest Coverage0.52x

    Returns and Efficiency

    Return on invested capital is -44.19% over the last 12 months, against a 5-year average of -19.80%.

    Return on Equity (ROE)-198.75%
    Return on Assets (ROA)-41.52%
    Return on Invested Capital (ROIC)-44.19%
    Return on Capital Employed (ROCE)-40.42%
    ROE (5Y Average)-60.52%
    ROA (5Y Average)-17.08%
    ROIC (5Y Average)-19.80%
    Asset Turnover0.33x
    Inventory Turnover2.46x
    Receivables Turnover10.98x
    Cash Conversion Cycle132 days

    Scores

    VALN has an Altman Z-Score of -2.02, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-2.02
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of EUR 143.51M over the last 12 months is down 26.90% from the 12 months before.

    RevenueEUR 143.51M
    Revenue Growth (YoY)-26.90%
    Gross ProfitEUR 23.47M
    Operating IncomeEUR -116.14M
    Pretax IncomeEUR -158.10M
    Net IncomeEUR -158.17M
    EBITDAEUR -93.22M
    EBITEUR -115.12M

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 20.89% of the EUR 388.12M in total assets.

    Working CapitalEUR 119.50M
    Shareholder EquityEUR 81.09M
    Tangible Book ValueEUR 60.18M
    Total AssetsEUR 388.12M
    Total LiabilitiesEUR 307.03M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After EUR 2.52M of capital spending, operating cash flow left EUR -85.67M of free cash flow.

    Operating Cash FlowEUR -83.15M
    Capital ExpendituresEUR 2.52M
    Free Cash FlowEUR -85.67M
    Depreciation and AmortizationEUR 21.90M

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -80.93%, against a 5-year average of -28.26%.

    Gross Margin16.35%
    Operating Margin-80.93%
    Pretax Margin-110.16%
    Net Margin-110.21%
    EBITDA Margin-64.96%
    EBIT Margin-80.22%
    FCF Margin-59.70%
    Gross Margin (5Y Average)34.23%
    Operating Margin (5Y Average)-28.26%
    Net Margin (5Y Average)-39.98%

    Growth

    Revenue fell 21.52% a year over 3 years.

    Revenue Growth (3Y CAGR)-21.52%
    Revenue Growth (5Y CAGR)+9.62%

    Revenue and profit by year

    Peer Position

    Against 7 similar companies, VALN has the 4th highest P/S and the 3rd highest ROIC.

    P/S Ratio3.2x vs 3.2x median
    ROIC-44.19% vs -84.61% median
    Revenue Growth (Trailing 4 Quarters, YoY)-26.90% vs -61.33% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About VALN

    What is VALN's market cap?

    Valneva SE ADR has a market cap of $538.42M.

    How many shares of VALN are outstanding?

    Valneva SE ADR has 94.82M shares outstanding. The count is up 23.25% from a year earlier.

    Does VALN pay a dividend?

    No. Valneva SE ADR does not pay a dividend.